chr17-5002851-GCC-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_006612.6(KIF1C):c.720+20delC variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 87 hom., cov: 0)
Exomes 𝑓: 0.12 ( 1071 hom. )
Consequence
KIF1C
NM_006612.6 intron
NM_006612.6 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.04
Publications
1 publications found
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
KIF1C Gene-Disease associations (from GenCC):
- spastic ataxia 2Inheritance: AR, AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 17-5002850-CGC-CG is Benign according to our data. Variant chr17-5002851-GC-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1167058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0533 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006612.6. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.0383 AC: 5240AN: 136808Hom.: 87 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5240
AN:
136808
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.183 AC: 35456AN: 193244 AF XY: 0.189 show subpopulations
GnomAD2 exomes
AF:
AC:
35456
AN:
193244
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.115 AC: 137136AN: 1188546Hom.: 1071 Cov.: 0 AF XY: 0.118 AC XY: 69589AN XY: 591930 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
137136
AN:
1188546
Hom.:
Cov.:
0
AF XY:
AC XY:
69589
AN XY:
591930
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1260
AN:
30250
American (AMR)
AF:
AC:
5412
AN:
36066
Ashkenazi Jewish (ASJ)
AF:
AC:
2559
AN:
20958
East Asian (EAS)
AF:
AC:
2919
AN:
32170
South Asian (SAS)
AF:
AC:
7293
AN:
67654
European-Finnish (FIN)
AF:
AC:
4763
AN:
42674
Middle Eastern (MID)
AF:
AC:
299
AN:
3780
European-Non Finnish (NFE)
AF:
AC:
107143
AN:
905558
Other (OTH)
AF:
AC:
5488
AN:
49436
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.388
Heterozygous variant carriers
0
7133
14267
21400
28534
35667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3640
7280
10920
14560
18200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0383 AC: 5236AN: 136878Hom.: 87 Cov.: 0 AF XY: 0.0358 AC XY: 2357AN XY: 65786 show subpopulations
GnomAD4 genome
AF:
AC:
5236
AN:
136878
Hom.:
Cov.:
0
AF XY:
AC XY:
2357
AN XY:
65786
show subpopulations
African (AFR)
AF:
AC:
674
AN:
36216
American (AMR)
AF:
AC:
505
AN:
13502
Ashkenazi Jewish (ASJ)
AF:
AC:
108
AN:
3306
East Asian (EAS)
AF:
AC:
9
AN:
4524
South Asian (SAS)
AF:
AC:
37
AN:
4082
European-Finnish (FIN)
AF:
AC:
241
AN:
8206
Middle Eastern (MID)
AF:
AC:
13
AN:
282
European-Non Finnish (NFE)
AF:
AC:
3508
AN:
64034
Other (OTH)
AF:
AC:
65
AN:
1858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
169
338
507
676
845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
not provided (1)
-
-
1
not specified (1)
-
-
1
Spastic ataxia 2 (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.